Wells Fargo
ISEE

Wells Fargo’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Wells Fargo’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-98,896
Closed -$3.89M – 7800
2023
Q2 		$3.89M Buy
98,896
+15,202
+18% +$537K ﹤0.01% 2349
2023
Q1 		$2.04M Buy
83,694
+77,154
+1,180% +$1.69M ﹤0.01% 2840
2022
Q4 		$140K Sell
6,540
-7,118
-52% -$152K ﹤0.01% 4361
2022
Q3 		$245K Sell
13,658
-2,662
-16% -$34.9K ﹤0.01% 4123
2022
Q2 		$156K Sell
16,320
-51,510
-76% -$647K ﹤0.01% 4411
2022
Q1 		$1.14M Sell
67,830
-38,937
-36% -$575K ﹤0.01% 3768
2021
Q4 		$1.78M Buy
106,767
+76,030
+247% +$1.25M ﹤0.01% 3613
2021
Q3 		$500K Buy
30,737
+11,190
+57% +$122K ﹤0.01% 4663
2021
Q2 		$123K Sell
19,547
-22,345
-53% -$144K ﹤0.01% 5220
2021
Q1 		$259K Sell
41,892
-132,323
-76% -$803K ﹤0.01% 5040
2020
Q4 		$1.2M Buy
174,215
+57,100
+49% +$365K ﹤0.01% 3890
2020
Q3 		$662K Buy
117,115
+93,223
+390% +$445K ﹤0.01% 4151
2020
Q2 		$123K Buy
23,892
+23,253
+3,639% +$96.9K ﹤0.01% 5138
2020
Q1 		$2K Sell
639
-100
-14% -$584 ﹤0.01% 6028
2019
Q4 		$7K Hold
739
– – ﹤0.01% 5986
2019
Q3 		$0 Sell
739
-27,190
-97% -$31.6K ﹤0.01% 6838
2019
Q2 		$36K Sell
27,929
-22,945
-45% -$31.5K ﹤0.01% 5657
2019
Q1 		$72K Buy
50,874
+11,239
+28% +$15.7K ﹤0.01% 5235
2018
Q4 		$47K Buy
39,635
+3,618
+10% +$7.01K ﹤0.01% 5547
2018
Q3 		$84K Sell
36,017
-1,400
-4% -$3.49K ﹤0.01% 5424
2018
Q2 		$102K Buy
37,417
+2,075
+6% +$5.72K ﹤0.01% 5371
2018
Q1 		$96K Buy
35,342
+2,182
+7% +$6.33K ﹤0.01% 5324
2017
Q4 		$103K Buy
33,160
+21,411
+182% +$60.2K ﹤0.01% 5292
2017
Q3 		$33K Buy
11,749
+11,650
+11,768% +$31.5K ﹤0.01% 5587
2017
Q2 		$0 Sell
99
-72,157
-100% -$197K ﹤0.01% 6519
2017
Q1 		$264K Sell
72,256
-24,279
-25% -$103K ﹤0.01% 4638
2016
Q4 		$465K Sell
96,535
-242,855
-72% -$7.21M ﹤0.01% 4246
2016
Q3 		$15.7M Sell
339,390
-13,029
-4% -$735K 0.01% 1455
2016
Q2 		$18M Buy
352,419
+288,514
+451% +$14.3M 0.01% 1398
2016
Q1 		$2.7M Sell
63,905
-3,151
-5% -$161K ﹤0.01% 2706
2015
Q4 		$5.26M Buy
67,056
+26,721
+66% +$1.55M ﹤0.01% 2284
2015
Q3 		$1.64M Buy
40,335
+2,664
+7% +$141K ﹤0.01% 3143
2015
Q2 		$1.96M Buy
37,671
+2,524
+7% +$126K ﹤0.01% 3111
2015
Q1 		$1.64M Buy
35,147
+4,574
+15% +$237K ﹤0.01% 3185
2014
Q4 		$1.37M Buy
30,573
+4,258
+16% +$179K ﹤0.01% 3299
2014
Q3 		$1.02M Sell
26,315
-712
-3% -$27.9K ﹤0.01% 3449
2014
Q2 		$1.14M Buy
27,027
+712
+3% +$26.1K ﹤0.01% 3427
2014
Q1 		$938K Buy
26,315
+26,313
+1,315,650% +$888K ﹤0.01% 3542
2013
Q4 		$0 Buy
+2
New +$59 ﹤0.01% 5982

Wells Fargo's ISEE Position: Q3 2023 in Review

Wells Fargo sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 98,896 shares — an estimated $3.89M sold.

Wells Fargo first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $18M in Q2 2016. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Wells Fargo reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Wells Fargo sold 98,896 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.89M.
  • Wells Fargo first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
  • Wells Fargo's IVERIC bio, Inc. Common Stock position peaked at $18M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.